Aeluma, Inc. (ALMU) 10-K Summary
Business Context and Reporting Period
Company: Aeluma, Inc.
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal year ended June 30, 2024
Business Overview: Aeluma develops novel optoelectronic devices for sensing and communications, utilizing compound semiconductor materials on large-diameter silicon substrates. The technology targets applications in LiDAR, 3D imaging, AR/VR, and mobile devices. The company operates a manufacturing and R&D facility in Goleta, California.
Key Financial Metrics
| Metric | Year Ended June 30, 2024 | Year Ended June 30, 2023 |
|---|---|---|
| Revenue | $918,554 | $193,339 |
| Net Loss | $(4,562,295) | $(5,379,582) |
| Operating Expenses | $5,481,862 | $5,703,024 |
| Cash and Cash Equivalents | $1,291,072 | $5,071,690 |
| Working Capital | $766,160 | $4,576,807 |
| Accumulated Deficit | $(13,624,361) | $(9,062,066) |
| Net Cash Used in Operating Activities | $(3,454,779) | $(3,637,972) |
Revenue Composition (2024): Government contracts accounted for $853,798 (93%), while commercial product and service contracts accounted for $64,756 (7%).
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased by 375.1% ($725,215) compared to the prior year, driven primarily by a significant increase in government contract revenue.
- Loss Reduction: Net loss decreased by 15.2% ($817,287) due to revenue growth and a 3.9% reduction in operating expenses, primarily from lower consulting costs.
- Liquidity Decline: Cash and cash equivalents decreased by approximately $3.78 million. Current assets dropped significantly, while current liabilities decreased slightly.
- Other Income: Other income decreased by 99.2% to $1,013, largely due to the expiration of a facility sub-lease in March 2023 which previously generated $128,921 in income.
Outlook, Risks, and Unusual Items
Going Concern Warning: The company's independent auditors have issued an explanatory paragraph regarding "Going Concern." The company has incurred significant operating losses and negative cash flows. Management states that existing cash is insufficient to complete the business plan, and the company's ability to continue as a going concern is dependent on raising additional capital.
Recent Financing:
- Convertible Notes: In August 2024 (subsequent to period end), the company issued convertible promissory notes totaling $3,145,000 to accredited investors. These notes mature in June 2026 and are convertible upon specific events.
- Private Placement History: Between Dec 2022 and May 2023, the company raised $6.05 million in gross proceeds via private placement.
Recent Contract Award: On September 6, 2024, the company was awarded an $11.717 million DARPA contract for nano-scale semiconductor development. $5.974 million is payable over 18 months, with the balance contingent on milestones.
Risks and Controls:
- Internal Controls: Management concluded that disclosure controls and procedures and internal control over financial reporting were ineffective as of June 30, 2024, citing insufficient personnel with technical accounting and SEC reporting expertise.
- Cybersecurity: The company relies on standard off-the-shelf software and has not implemented a formal process for assessing cybersecurity risks due to its small size.
- Customer Concentration: Revenue is heavily concentrated in government contracts. In 2024, Customer A accounted for 36.2% and Customer B for 30.5% of total revenue.
Investor Verification Checklist
- Cash Runway: Verify the sufficiency of the $1.29 million cash balance against the burn rate of ~$3.45 million annually to assess immediate liquidity risk.
- Financing Terms: Review the specific conversion terms and dilution impact of the $3.145 million convertible notes issued in August 2024.
- DARPA Milestones: Monitor the progress and milestone achievement of the $11.7 million DARPA contract to confirm future revenue recognition.
- Internal Control Remediation: Assess the company's plan to address the material weakness in internal controls over financial reporting.
- Government Dependency: Evaluate the risk associated with the high concentration of revenue from government agencies and the potential impact of funding changes.